Additional testing of FISH-negative tests for renal cell carcinoma can improve kidney cancer diagnosis

Additional testing of FISH-negative tests for renal cell carcinoma can improve kidney cancer diagnosis

A study from the University of Michigan Health Rogel Cancer Center and Department of Pathology shows that further testing in renal cell carcinoma with an overexpression of gene TRIM63 could uncover a mutation otherwise undetected, leading to more treatment options for patients.

Enhanced Testing Advances Kidney Cancer Diagnosis

A groundbreaking study from the University of Michigan Health Rogel Cancer Center and its Department of Pathology sheds new light on the diagnosis of renal cell carcinoma (RCC), specifically the microphthalmia-associated transcription factor (MiTF) family altered RCC. Renal cell carcinoma, a malignancy originating in the kidney, presents diagnostic challenges, particularly within the MiTF subtype, which […]

Additional Testing Can Improve Kidney Cancer Diagnosis

A study from the University of Michigan Health Rogel Cancer Center and Department of Pathology shows that further testing in renal cell carcinoma with an overexpression of gene TRIM63 could uncover a mutation otherwise undetected, leading to more treatment options for patients.